Antitrust Under Trump: April 2025 Updates

By Jon B. Dubrow, Michelle Lowery and Megan Ingram on April 29, 2025

Posted In Consumer Protection/Privacy, DOJ Developments, FTC Developments, Mergers & Acquisitions

The Trump administration’s antitrust landscape continues to develop with key changes in industry and policy priorities, remedy expectations, and agency personnel. Among the updates, Mark Meador was confirmed as a commissioner of the Federal Trade Commission, President Trump signed an executive order to eliminate anticompetitive regulations, and the Department of Justice is partial to populist antitrust with the “America First” movement. These changes signal a shift in antitrust enforcement, with a focus on reducing regulatory burdens and addressing competitive issues in key sectors like healthcare, transportation, and entertainment.

Jon B. Dubrow
Jon Dubrow is the US head of McDermott’s Antitrust Group and a strategic advisor to clients across a host of interrelated antitrust issues, including mergers and acquisitions (M&A) transactions and merger clearance, counseling, and litigation. He leads the defense of mergers, acquisitions and joint ventures before the Department of Justice, the Federal Trade Commission and other international competition authorities. Jon also regularly assists third parties whose interests are adversely affected by proposed transactions. Jon also is experienced in antitrust litigation. He provides counseling on distribution issues, contracting arrangements and a wide variety of other competition-related matters. Read Jon Dubrow's full bio.

Michelle Lowery
Michelle Lowery is the go-to litigator for West Coast state and federal antitrust and unfair competition matters and for California Attorney General antitrust and general litigation matters. She has nearly two decades of experience achieving exceptional results for clients in antitrust and unfair competition litigation and investigations, including class actions. Read Michelle Lowery's full bio.

Megan Ingram
Megan Ingram focuses her practice on assessing and mitigating antitrust risk in public and private M&A transactions. She supports US and international clients with merger review, obtaining clearance under the Hart-Scott-Rodino Act, antitrust compliance, and governmental antitrust investigations. Megan has experience across multiple industries, including software and technology, healthcare and life sciences, consumer products, aerospace and defense, and industrials. Read Megan Ingram's full bio.

Antitrust Under Trump: April 2025 Updates

Related Posts

BLOG EDITORS

STAY CONNECTED

TOPICS

ARCHIVES

RECENT POSTS